Načítá se...
Near-infrared optical imaging in glioblastoma xenograft with ligand targeting α3 integrin
PURPOSE: Patients with glioblastoma usually have a very poor prognosis. Even with a combination of radiotherapy plus temozolomide, the median survival of these patients is only 14.6 months. New treatment approaches to this cancer are needed. Our purpose is to develop new cell-surface binding ligands...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2008
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2842018/ https://ncbi.nlm.nih.gov/pubmed/18712382 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-008-0920-0 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|